Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03517657 |
|
Recruitment Status :
Recruiting
First Posted : May 7, 2018
Last Update Posted : October 7, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Stroke | Behavioral: Bilateral Motor Priming + Task Specific Training (BMP + TST) Behavioral: Control Priming + TST (CP + TST) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 76 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Patients are stratified by Fugl Meyer score. After stratification, patients will be randomized to one of two groups |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis |
| Actual Study Start Date : | January 20, 2018 |
| Estimated Primary Completion Date : | January 30, 2023 |
| Estimated Study Completion Date : | March 30, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Bilateral motor priming + Task specific training (BMP + TST)
A combination of bilateral motor priming (BMP) plus task specific training (TST) for 30 hours over 5 weeks.
|
Behavioral: Bilateral Motor Priming + Task Specific Training (BMP + TST)
Priming will always precede task specific training. During bilateral motor priming, the "Rocker" (Exsurgo Bilateral Primer, Aukland, New Zealand) will be used. For the individuals assigned to the bilateral priming group, both hands will be strapped in place in the vertically oriented plates which are attached via a mechanical linkage. They will move both wrists in rhythmic, symmetrical wrist flexion and extension for 15 minutes at a frequency of 1 Hz as cued by a metranome. Subjects do not need to have active flexion and extension of the affected hand as the less affected arm drives the weaker one (through an acutator underneath the surface) in in-phase bilateral symmetrical movement.
Other Name: Active-Passive Bilateral Therapy |
|
Active Comparator: Control Priming + TST (CP + TST)
The control priming is transcutaneous electric stimulation (TENS) set at a low threshold followed by the same task specific training protocol for 30 hours over 5 weeks.
|
Behavioral: Control Priming + TST (CP + TST)
The control priming intervention for the active comparator group will be intermittent cutaneous electric stimulation of the volar aspect of the paretic forearm, using a standard TENS unit delivered for 15 seconds (including 2-second ramp-up, 2-second ramp-down), once per minute, for 15 minutes. Intensity will be minimized
Other Name: Transcutaneous Electric Stimulation |
- Fugl Myer Test of Upper Extremity Function [ Time Frame: Change in baseline Fugl Myer Score at follow-up (8 weeks after treatment ends) ]Examines upper extremity impairment looking at synergy and isolated movement
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- FMUE TEST score of 23 to 38
- evidence of stroke without involvement of cerebellum at least 6 months prior to enrollment;
- 0-3 wrist flexion/wrist extension on Modified Ashworth Scale
Exclusion Criteria:
- orthopedic conditions of less affected or affected wrist
- MMSE of lower than 21
- metal implant or fragments in head or neck area
- history of seizures, epilepsy or convulsions
- previous concussion associated with LOC
- ringing in ears; cochlear implants
- history of persistent headaches
- presence of pacemaker or neurostimulator
-
pregnant women
- Metastatic cancer
- Other neurological conditions (as in Cerebral Palsy or Parkinson's)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03517657
| Contact: mary E Stoykov, PhD | 312-503-3106 | mstoykov@sralab.org | |
| Contact: Alexandra Wax, MS | 312-238-2866 | alexandra.wax@northwestern.edu |
| United States, Illinois | |
| Northwestern University and Shirley Ryan Ability Lab | Recruiting |
| Chicago, Illinois, United States, 60611 | |
| Contact: Mary E Stoykov, PhD 312-503-3106 mary-stoykov@northwestern.edu | |
| Contact: Alexandra Wax, MS, OTR/L 312-238-1167 awax@sralab.org | |
| Northwestern University | Recruiting |
| Chicago, Illinois, United States, 60613 | |
| Contact: Mary E Stoykov 312-503-3106 | |
| Principal Investigator: | Daniel M Corcos, PhD | Northwestern University |
| Responsible Party: | Daniel Corcos, Professor, Department of Physical Therapy and Human Movement Sciences, Northwestern University |
| ClinicalTrials.gov Identifier: | NCT03517657 |
| Other Study ID Numbers: |
STU00205857 |
| First Posted: | May 7, 2018 Key Record Dates |
| Last Update Posted: | October 7, 2021 |
| Last Verified: | October 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
upper limb occupational therapy bilateral priming |
|
Paresis Neurologic Manifestations Nervous System Diseases |

